The glucosidase inhibitors 1 -deoxynojirimycin, N-methyl-I -deoxynojirimycin and castanospermine were used to inhibit oligosaccharide processing in primary cultures of rat hepatocytes. Their effect on the glycosylation of z1-proteinase inhibitor (a,PI) and a,-acid glycoprotein (azAGP) was studied. Of the three glucosidase inhibitors examined, 1-deoxynojirimycin inhibited not only oligosaccharide trimming but also glycosylation de novo of newly synthesized proteins, resulting in the formation of a1PI with two and three (normally carrying three) and acAGP with two to five (normally carrying six) oligosaccharide side chains.
INTRODUCTION
The majorpathway for the biosynthesis ofcomplex-type oligosaccharides begins with the co-translational transfer ofoligosaccharidesofthecompositionGGlc3MangGlcNAc2 from their dolichol derivatives to certain asparagine residues of nascent proteins (Hubbard & Ivatt, 1981; Snider & Robbins, 1981; Hanover & Lennarz, 1981; . The processing ofthese oligosaccharides starts in the endoplasmic reticulum with the removal of three glucose residues. Thus, glucosidase I removes the peripheral al ,2-linked glucose, whereas glucosidase II removes the two inner al,3-linked glucose residues Ugalde et al., 1978; Hubbard & Robbins, 1979; Grinna & Robbins, 1979; Burns & Touster, 1982) . Subsequently, six mannose residues are removed by mannosidases I and II in the Golgi complex Tulsiani et al., 1982a) . More recently, mannosidase activity has been found in the endoplasmic reticulum, which might also be involved in the oligosaccharide trimming (Bischoff & Kornfeld, 1983) . The formation ofthecomplex-type oligosaccharides is completed in the Golgi complex by the addition of GlcNAc, galactose, fucose and sialic acid (Hubbard & Ivatt, 1981) .
Specific inhibitors of the individual steps of the trimming pathway have now been described (for a review, see . Swainsonine has been found to be a potent inhibitor of mannosidase II (Elbein et al., 1981; Tulsiani et al., 1982b) , and 1-deoxymannojirimycin was found to inhibit Golgi mannosidase I (Fuhrmann et al., 1984; Bischoff & Kornfeld, 1984) . Various compounds have been described as inhibitors of the glucosidase reactions: nojirimycin (Peyrieras et al., 1983) , bromoconduritol (Datema et al., 1982) , 1- deoxynojirimycin (Saunier et al., 1982) , castanospermine , N-methyl-1-deoxynojirimycin (Romero et al., 1983) , 2,5-dihydroxymethyl-3,4-dihydroxypyrrolidine .
In previous experiments we have studied the effect of several inhibitors of the trimming pathway on the glycosylation of a1PI in primary cultures of rat hepatocytes. We have found that, in the presence of swainsonine, hepatocytes secreted acPI carrying oligosaccharides of the hybrid type (Gross et al., 1983a) . Hepatocytes treated with 1-deoxymannojirimycin secreted a1PI of the high-mannose type (Gross et al., 1985) . Addition of 1-deoxynojirimycin to hepatocyte primary cultures led to the formation of axPI carrying both high-mannose and complex-type oligosaccharides (Gross et al., 1983b) . From the work of Hettkamp et al. (1984) it is known that N-methyl-I -deoxynojirimycin has a lower Ki for glucosidase I than does 1-deoxynojirimycin, whereas 1 -deoxynojirimycin has alower Ki for glucosidase II than does N-methyl-l-deoxynojirimycin. A similar Ki to that of N-methyl-l-deoxynojirimycin for glucosidase I can be estimated for castanospermine (Pan et al., 1983) .
Since 1-deoxynojirimycin did not lead to a complete inhibition of glucose trimming in our hepatocyte system (Gross et al., 1983b) (1979) . Swainsonine was a present from Dr. K. Vosbeck, Ciba-Geigy, Basel, Switzerland.
Preparation of rat hepatocyte monolayers
This was done as previously described (Bischoff et al., 1976) . After the cells were washed with Krebs-Henseleit buffer, they were suspended in a modified Waymouth medium (Gebhardt & Mecke, 1979) The supernatant from this centrifugation and the culture medium were used for the immunoprecipitations.
Immunoprecipitation
For this, 1.5-2.5 ml of medium or 0.4-0.8 ml of the supernatant obtained from the cell homogenate were added to 5 ml of 20 mM-Tris/HCl (pH 7.6)/0.14 MNaCl/5 mM-EDTA/1 % Triton X-100 containing 1 mMphenylmethanesulphonyl fluoride and 0.1 mg of kallikrein trypsin inhibitor (kindly provided by Bayer A. G., Wuppertal-Elberfeld). After addition of 7.5 ,l of a specific antiserum against rat ax1PI (Gross et al., 1983c) or rat a,AGP (Gross et al., 1984) and incubation at 0°C overnight, the antigen-antibody complexes were bound to 7 mg (dry wt.) of protein A-Sepharose and washed four times with the above-mentioned buffer and twice with 50 mM-sodium phosphate buffer, pH 7.5. Elution was performed by incubation with 0.1 M-Tris/HCl (pH 6.8)/5% ,-mercaptoethanol/5% SDS/10% glycerol at 95°C for 5 min. The eluted proteins were analysed by electrophoresis in SDS/polyacrylamide slab gels (King & Laemmli, 1971 ) and fluorography (Bonner & Laskey, 1974) .
Treatment of a1-proteinase inhibitor and a,-acid glycoprotein with endoglucosaminidase H The glycoprotein-IgG complexes eluted from the protein A-Sepharose were dialysed exhaustively against 50 mM-phosphate buffer (pH 6.0)/0.01 % SDS and incubated in a total volume of 0.1 ml with 5 munits of endoglucosaminidase H at 37°C for 16 h. Bio-Gel P4 chromatography of oligosaccharides
[3H]Mannose-labelled oligosaccharides of a1PI obtained after digestion with endoglucosaminidase H were subjected to Bio-Gel P-4 chromatography. Bio-Gel P-4 (-400 mesh) columns (1 cm x 150 cm), eluted with water containing 0.02% NaN3, were used. The void-volume marker was bovine serum albumin (Datema & Schwarz, 1981) . The volume of the fractions was 0.35 ml. Radioactivity was determined with a Packard Tri-Carb liquid-scintillation spectrophotometer model 460 C. Treatment of oligosaccharides with a-glucosidase was done as described by Grinna & Robbins (1979) , modified by addition of 10 mM-EDTA to inhibit residual mannosidase as described by Datema et al. (1982) . Concanavalin A-Sepharose chromatography of glycopeptides from al-proteinase inhibitor and a,-acid glycoprotein After immunoprecipitation, the glycoprotein-IgG complexes were eluted from the protein A-Sepharose by incubation with 20 mM-Tris/HCI (pH 7.5)/2% SDS at 95°C for S min. Glycopeptides were prepared by 1986 digestion with 1 mg of proteinase K/ml in 20 mmTris/HCI (pH 7.5)/0.15 M-NaCl/0.2% SDS at 37°C for 18 h. The reaction was stopped by the addition of 1 mM-phenylmethanesulphonyl fluoride and subsequent treatment at 95°C for 10 min. The incubation mixture, diluted with concanavalin A buffer (10 mM-Tris/HCl, pH 7.5, 0.3 M-NaCl, 1 mM-CaCl2, 1 mM-MgCl2, 1 mMMnC12), to a final SDS concentration of 0.02%, was then loaded on to a concanavalin A-Sepharose column (3 ml bed volume) equilibrated with the same buffer. The column was washed with equilibration buffer, followed by elution with 9.75 ml of 10 mM-a-methyl glucoside and then 9.75 ml of 500 mM-a-methyl mannoside. Fractions of volume 0.65 ml were collected and their radioactivity was determined. for the largest forms of oqPI and azAGP respectively. acPI and c&1AGP secreted by hepatocytes treated with glucosidase inhibitors were of smaller apparent Mr than the same glycoproteins secreted by control cultures (51000 instead of 54000 for acPI; 43000 instead of 43000 60000 for cxAGP). In the presence of N-methyl-1-deoxynojirimycin and castanospermine, intracellular acAGP has a lower electrophoretic mobility than the secreted ajAGP. The latter, however, is also detected intracellularly (Fig. lb, lanes marked 'mdN' and 'CS').
This effect can hardly be seen with ac1PI, because of the much smaller carbohydrate content (13.2%; Ikehara et al., 198 1), compared with ajAGP (34-37% ; Nagashima et al., 1980) . In contrast with N-methyl-l-deoxynojirimycin and castanospermine, 1-deoxynojirimycin led to the formation of oa,PI and acAGP with less than the number of oligosaccharide chains normally found, namely three for acPI (Gross et al., 1982; Carlson & Stenflo, 1982) and six for o1AGP (Yoshima et al., 1981; Baumann & Jahreis, 1983) . In the presence of 5 mm-1-deoxynojirimycin, a,xPI with two and three, and acAGP with two to five, carbohydrate side chains were found. This is evident from Fig. 1 , where the forms of cx1PI and z1AGP with a lower number of oligosaccharide side chains represent distinct bands of lower Mr (see lanes marked 'dN'). Measurements of the radioactivity in individual bands of Fig. 1 showed that, of the three glucosidase inhibitors, only 1-deoxynojirimycin led to a marked inhibition of the secretion of aczPI and ajAGP, by about 50%, whereas the secretion of the two glycoproteins was not affected by N-methyl-l-deoxynojirimycin or castanospermine. The inhibition ofglycoprotein secretion by 1-deoxynojirimycin was not due to its inhibitory effect on glycosylation de novo, since the underglycosylated forms of a1PI with two carbohydrate . : : i : ; . X . ! ? o 2 X * . : . : : : : : : . . N N ' : a n .. }, .< * :. :. ,2
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.. ........ * X . : : . . . (Fig. 2) and Man7GlcNAc appeared after a-glucosidase treatment. Similar results to those with castanospermine were obtained with N-methyl-I -deoxynojirimycin (not shown).
The oligosaccharides of a1PI and a1AGP secreted by hepatocytes treated with a glucosidase inhibitor were further characterized by affinity chromatography on concanavalin A-Sepharose (Fig. 4) . cx1PI and a1AGP labelled in their oligosaccharide part with [3H]mannose were immunoprecipitated from the media of control hepatocyte cultures or from the media of cultures incubated with the glucosidase inhibitors -deoxynojirimycin, N-methyl-l -deoxynojirimycin or castanospermine, and/or the mannosidase II inhibitor swainsonine. After digestion of the denatured proteins by proteinase K, the glycopeptides were subjected to concanavalin A-Sepharose chromatography and divided into three fractions (Reitman et al., 1982) : A, glycopeptides that did not bind to concanavalin A (mainly threeand higher-antennary complex-type oligosaccharides); B, glycopeptides that could be eluted by 10 mM-a-methyl glucoside (mainly biantennary complex-type oligosaccharides); C, glycopeptides that could be eluted by 500 mM-a-methyl mannoside (high-mannose type and hybrid-type oligosaccharides). Fig. 4 Rat hepatocyte primary cultures were incubated without (Co) or with 2,ug of swainsonine/ml (SW), 5 mm-ldeoxynojirimycin (dN), 5 mM-l-deoxynojirimycin+2#ug
of swainsonine/ml (dN + SW), 5 mM-N-methyl-l-deoxynojirimycin (mdN), 5 mM-N-methyl-l-deoxynojirimycin + 2 ,ug of swainsonine/ml (mdN + SW), 100 ,ug of castanospermine/ml (CS), or 100 jg of castanospermine/ml + 2 ,ug of swainsonine/ml (CS + SW Glucosidase inhibitors and glycoprotein processing by paper chromatography. As shown in Fig. 5, [3H]galactose-labelled a1PI and acAGP were detected under these conditions. Since inhibition of mannosidase II by swainsonine is complete (Gross et al., 1983a) , it must be concluded that the glucosidase inhibitors do not completely block processing of the glucosylated al,3-linked antenna of newly synthesized oligosaccharides.
DISCUSSION
Nojirimycin (Peyrieras et al., 1983) , bromoconduritol (Datema et al., 1982) , 1 -deoxynojirimycin (Saunier et al., 1982) , castanospermine and N-methyl-1-deoxynojirimycin (Romero et al., 1983) have been described as inhibitors of the processing glucosidases involved in the biosynthesis of N-linked complex type oligosaccharides. Several authors have studied the effect of these inhibitors in different systems (Datema et al., 1982 Gross et al., 1983b; Hori et al., 1984; Lemansky et al., 1984; Pan et al., 1983; Peyrieras et al., 1983; Romero et al., 1983 Romero et al., , 1985a Saul et al., 1983; Saunier et al., 1982; Schlesinger et al., 1984; Burke et al., 1984) . In the present study we have compared the effects of 1-deoxynojirimycin, N-methyl-l-deoxynojirimycin and castanospermine on the glycosylation of ajPI and a,AGP by rat hepatocytes in primary culture. We obtained different results for 1-deoxynojirimycin on the one hand and for N-methyl-l-deoxynojirimycin and castanospermine on the other. Bromoconduritol was not included in this study, since it turned out to be toxic for the hepatocytes when used in the concentrations needed for glucosidase inhibition (Datema et al., 1982) . Nojirimycin was excluded also, since it leads to the formation of drastically shortened oligosaccharides (Peyrieras et al., 1983) .
Whereas N-methyl-1-deoxynojirimycin and castanospermine did not affect glycosylation de novo of azPI and acAGP, 1-deoxynojirimycin led to the formation of underglycosylated acPI carrying two and three instead of three, and ajAGP with two to five instead of six, oligosaccharide chains. A similar observation has been published by Lemansky et al. (1984) , who found increased amounts of a f-chain precursor of ,-hexosaminidase lacking one of its carbohydrate side chains in the presence of 1-deoxynojirimycin. The decrease in the number of oligosaccharide side chains observed after 1-deoxynojirimycin might be explained by the inhibition of the formation of Glc3Man9GlcNAc2-PP-dolichol, which has been observed in intestinal epithelial cells by Romero et al. (1985b) . Since Glc3Man9GlcNAc is the preferred substrate for the transfer to protein (Hubbard & Ivatt, 1981) , the decrease in Glc3Man9GlcNAc2-PP-dolichol donor in 1-deoxynojirimycin-treated cells may account for the incomplete glycosylation of alPI and ajAGP.
Oligosaccharides of different compositions were found to accumulate in the presence of 1-deoxynojirimycin and the other two glucosidase inhibitors. In the presence of 1-deoxynojirimycin, mainly oligosaccharides partially processed in their glucose but not in their mannose moieties were found, the predominant species having the composition Glc,MangGlcNAc. Castanospermine and N-methyl-l-deoxynojirimycin, however, led mainly to the formation of oligosaccharides processed not in their glucose but in their mannose moieties, i.e. Glc3Man9GlcNAc, Glc3Man8GlcNAc, Glc3Man7GlcNAc and possibly Glc3Man,GlcNAc.
Obviously, N-methyl-i -deoxynojirimycin and castanospermine are more effective inhibitors of glucosidase I in our hepatocyte system than is 1-deoxynojirimycin. Our results are in agreement with those of Romero et al. (1985a) , who found in rat intestinal epithelial cells that about 70% of the endoglucosaminidase-H-sensitive oligosaccharides formed in the presence of N-methyl-1-deoxynojirimycin contain three glucose residues, compared with only about 20% of the corresponding oligosaccharides of the 1-deoxynojirimycin-treated cells.
Of the three glucosidase inhibitors, only 1-deoxynojirimycin inhibited the secretion of ajAGP and ajPI by about 50%, whereas castanospermine and N-methyl-ldeoxynojirimycin had no comparable effect. This finding suggests that aLPI and aLAGP with oligosaccharides containing only one glucose residue are less effectively secreted than the same glycoproteins carrying carbohydrate side chains containing three glucose residues. The fact that there is hardly any mannose trimming in the endoglucosaminidase-H-sensitive oligosaccharide chains ofintracellular a1PI in the presence of 1-deoxynojirimycin reflects the inhibition of the intracellular transport of this protein in the rough endoplasmic reticulum. This has been demonstrated directly by Lodish & Kong (1984) with HepG2 cells. A general inhibitory effect of 1-deoxynojirimycin on protein secretion is not probable. It was shown that 1-deoxynojirimycin has no effect on the secretion of albumin in primary cultures of rat hepatocytes (Gross et al., 1983b) . Whereas 1-deoxynojirimycin greatly decreased the rate of secretion of ajPI and a1-antichymotrypsin by human hepatoma HepG2 cells, it had only marginal effects on the secretion of the glycoproteins C3 and transferrin or of albumin (Lodish & Kong, 1984) . In IgD-and IgM-producing hybridoma cells, Peyrieras et al. (1983) found that the secretion of IgD, but not that of IgM, was blocked by 1-deoxynojirimycin.
In our system none of the three glucosidase inhibitors totally blocked the formation of complex-type oligosaccharides in the secreted form of a1PI and a1AGP. This was demonstrated by the existence of endoglucosaminidase-H-resistant oligosaccharides (Fig. 2) and by experiments where, in addition to the processing glucosidases, mannosidase II was inhibited by swainsonine (Figs. 4 and 5). Similar findings have been reported by Reitman et al. (1982) , using a mouse lymphoma cell line deficient in glucosidase II. In spite of the nearly complete lack of glucosidase II in these cells, the synthesis ofcomplex-type oligosaccharides was only decreased by 75%o. The existence of endoglucosaminidase-H-resistant oligosaccharides has been observed in the presence of castanospermine by Pan et al. (1983) and in the presence of 1-deoxynojirimycin by Lemansky et al. (1984) . The incomplete inhibition of oligosaccharide processing by 1-deoxynojirimycin, N-methyl-i-deoxynojimycin or castanospermine, resulting in the secretion of axPI and a1AGP molecules carrying together high-mannose and complex-type oligosaccharide side chains, might be explained either by incomplete inhibition of the trimming glucosidases by these inhibitors in vivo, which would be in contrast with their lower Ki values measured in vitro, or by the fact that only a part of the oligosaccharides is transferred as glucosylated species from their dolichol derivatives to the nascent polypeptide chains.
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